Metraipolis › archive › dc_664ce6edf3ee

Ceftazidime-Avibactam as Early Empiric Therapy for Gram-Negative Nosocomial Infections: A Risk-Stratified Empiric Use Informed by National AMR Surveillance… — Europe PMC PMID:42505656

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42505656
DOI
10.3390/antibiotics15070693
License (as archived)
solo-consultazione
Archived
2026-10-18T10:38:42.772Z
SHA-256 of the archived text
57611ea67ebf0d34fed73c4e902097c710666d87fc4ec35e4ad6ed1fca87719f
Stable URL of this page
https://metraipolis.com/documento/dc_664ce6edf3ee

How to cite

Ceftazidime-Avibactam as Early Empiric Therapy for Gram-Negative Nosocomial Infections: A Risk-Stratified Empiric Use Informed by National AMR Surveillance… — Europe PMC PMID:42505656 — Europe PMC (en), https://europepmc.org/article/MED/42505656 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_664ce6edf3ee (Metraipolis archive dc_664ce6edf3ee, sha256 57611ea67ebf0d34fed73c4e902097c710666d87fc4ec35e4ad6ed1fca87719f)
BibTeX
@misc{dc664ce6edf3ee,
  title = {Ceftazidime-Avibactam as Early Empiric Therapy for Gram-Negative Nosocomial Infections: A Risk-Stratified Empiric Use Informed by National AMR Surveillance… — Europe PMC PMID:42505656},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42505656},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_664ce6edf3ee; sha256 57611ea67ebf0d34fed73c4e902097c710666d87fc4ec35e4ad6ed1fca87719f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42505656. Agents can read the archived copy with the MCP tool read_document.